Status:
UNKNOWN
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
Lead Sponsor:
Assiut University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-35 years
Phase:
PHASE4
Brief Summary
Stein and Leventhal were the first to recognize an association between the presence of polycystic ovaries and signs of hirsutism and amenorrhea (eg,oligomenorrhea, obesity), After women diagnosed with...
Eligibility Criteria
Inclusion
- Women under 35 years with polycystic ovary syndrome criteria
- Normal male semen parameters
- Normal tubes either by hysterosalpingography \&/or laparoscopy
- Free from other endocrine abnormalities
Exclusion
- NON polycystic ovary syndrome Criteria
- More than 35 years
- Abnormal semen parameters
- Pathological tube\& pelvic factor
- Other endocrine disorders
Key Trial Info
Start Date :
December 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04094467
Start Date
December 7 2019
End Date
January 1 2021
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Abbas
Assiut, Cairo Governorate, Egypt, 002